Medicinal composition for treating leukemia

Abstract

The invention relates to a medicinal composition for treating leukemia. The medicinal composition is prepared from the following raw materials in parts by weight: 15 to 25 parts of rhizoma sparganii, 15 to 25 parts of ligusticum wallichii, 10 to 20 parts of American ginseng, 10 to 25 parts of barbed skullcap herb, 10 to 15 parts of rhizoma anemarrhenae, 10 to 15 parts of longhairy antenoron herb, 10 to 15 parts of fructus psoraleae, 10 to 15 parts of radix polygonati officinalis, 5 to 10 parts of fructus viticis, 10 to 25 parts of honeysuckle stem, 10 to 25 parts of ash bark, 10 to 30 parts of angelica sinensis, 10 to 20 parts of herba patriniae, 10 to 30 parts of pseudo-ginseng, 10 to 30 parts of starwort root, 5 to 10 parts of bamboo shavings, 5 to 10 parts of gizzard pepsin, 5 to 10 parts of fructus evodiae, 5 to 10 parts of tuber fleeceflower stem, 15 to 30 parts of garden burnet, 15 to 30 parts of radix stephaniae tetrandrae, and 5 to 15 parts of white paeony root. The medicinal composition has the effects of eliminating pathogen and strengthening vital qi, clearing heat and removing toxicity, softening hardness and dissipating stagnation, and invigorating spleen-stomach and replenishing qi, can activate the hematopoietic function of bone marrow, and is used for treating leukemia, free of toxic or side effect, and remarkable in treatment effect.

Description

technical field [0001] The invention relates to a pharmaceutical composition, in particular to a pharmaceutical composition for treating leukemia. Background technique [0002] Leukemia is a malignant tumor of the hematopoietic system, characterized by the progressive and uncontrolled abnormal proliferation of white blood cells and their immature cells, as well as immature red blood cells or megakaryocytes (ie, leukemia cells) in the bone marrow or other hematopoietic tissues, infiltrating the whole body Various tissues and organs, and enter the peripheral blood. Leukemia is especially common in children and young people, and it ranks first in children and people under the age of 35. According to the degree of leukemia cell maturity and the natural process of leukemia, leukemia can be divided into two categories: acute leukemia and chronic leukemia. Acute leukemia has a sudden onset, and symptoms such as anemia, hemorrhage, secondary infection, and fever are caused by the ...

AI Technical Summary

Problems solved by technology

[0003] At present, the common treatment methods are radiotherapy and chemotherapy and bone marrow transplantation, etc., but the side effects of radiotherapy and chemotherapy are very large, destroying the immune function of the human body and the ability to resist leukemia, especially while killing leukemia cells, it also seriously damages the normal bone marrow cell system , so that chemotherapy can not continue, severe bleeding, infection loss of treatment means, resulting in death of the patient; bone marrow transplantation due to difficulty in bone marrow source, low success rate, many transplant complications, recurrence rate within 5 years as high as 70%, aggravating the suffering of patients, and Expensive and imposes a severe financial burden on patients and the government

In recent years, there have been many studies on the treatment of leukemia with traditional Chinese medicine, but there is a lack of systematic clinical research on the treatment of leukemia with traditional Chinese medicine, and the curative effect is not accurate enough.